Roderick O'Day

Dr. Roderick O'Day


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
KRKelsey Roelofs
Kelsey Roelofs
RORoderick O'Day
Roderick O'Day
LALamis Alharby
Lamis Alharby
GHGordon Hay
Gordon Hay
AAAmit K. Arora
Amit K. Arora
Bertil E. DamatoBertil E. Damato
Bertil E. Damato
Purpose: To determine if ultrasonography is necessary to detect progression of choroidal melanocytic tumors undergoing sequential multi-modal imaging with color photography, autofluorescence (AF) and optical coherence tomography (OCT). Methods: All patients with choroidal melanoma undergoing treatment at Moorfields Eye Hospital between January 2016 and March 2020 were reviewed to identify those with treatment deferred by ≥2 months. Tumors that showed progression prior to treatment, defined as an increase in (a) basal dimensions (b) thickness (c) orange pigment and/or (d) sub-retinal fluid, were included. Mushroom shape, Orange pigment, Large size, Enlargement and Sub-retinal fluid (MOLES) scores were assigned to all tumors at earliest date and date of treatment. Results: A total of 99 patients with a mean age of 66 years (range: 26–90) were included. The initial MOLES score was 1 in 2 cases, 2 in 23 cases, and ≥3 in 74 cases. Progression was detected with sequential color photography alone in 100% of MOLES 1/2 and 97% of lesions with a MOLES score of ≥3. When findings on AF and OCT were included, sensitivity for detecting subtle change without ultrasonography improved to 100% for MOLES 3 and 97% for MOLES 4/5. Only one patient included in this study had an isolated increase in thickness that may have been missed had sequential ultrasonography not been performed. Overall, the sensitivity for detecting progression with color photographs alone was 97% (95% CI 93–100%) and increased to 99% (95% CI 97–100%) by including autofluorescence and OCT. Conclusions: Monitoring of choroidal nevi, particularly those classified as MOLES 1 or 2 (i.e., low-risk or high-risk naevi), can be accomplished safely without the need for ultrasonography. The findings of this study may remove barriers to the implementation of tele-oncology clinics for the monitoring of choroidal melanocytic tumors.

17 October 2023 in Ophthalmology Retina
Verified
Journal Article
Closed access
AHAlison Hiong
Alison Hiong
RORoderick O'Day
Roderick O'Day
LFLotte S. Fog
Lotte S. Fog
DMDaniel McKay
Daniel McKay
JMJohn McKenzie
John McKenzie
MSMark Shackleton
Mark Shackleton

2 July 2018 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
RORoderick O'Day
Roderick O'Day
CHC Alex Harper
C Alex Harper
SWSanjeewa S Wickremasinghe
Sanjeewa S Wickremasinghe

13 February 2022 in Clinical and Experimental Optometry
Verified
Journal Article
Closed access
JFJeremy Pm Flanagan
Jeremy Pm Flanagan
RORoderick O'Day
Roderick O'Day
KRKelsey A Roelofs
Kelsey A Roelofs
MMMyra McGuinness
Myra McGuinness
PWPeter van Wijngaarden
Peter van Wijngaarden
BDBertil E Damato
Bertil E Damato
Although melanocytic choroidal tumours of the choroid are a common eye pathology, no standardised protocol exists for their management in the community.Choroidal naevi are found in approximately 6%...

28 January 2020 in Ocular Oncology and Pathology
Verified
Journal Article
Open access
PDF file
KRKelsey Roelofs
Kelsey Roelofs
RORoderick O'Day
Roderick O'Day
CTCaroline Thaung
Caroline Thaung
Bertil E. DamatoBertil E. Damato
Bertil E. Damato
We report a 61-year-old female who presented to our service with recent growth of a thickened, pigmented, sub-conjunctival lesion within an area of ocular melanocytosis in her left eye. Lamellar sclerectomy was performed. Histopathological assessment revealed a localized melanocytic proliferation with features of blue nevus arising within the area of ocular melanocytosis. There was a small zone of cells showing cytological atypia and expansion of the scleral stroma. We believe this case to be the first report of intrascleral blue nevus arising within an area of ocular melanocytosis. Given the cytological atypia, the blue nevus may perhaps represent an intermediate stage within a progression from ocular melanocytosis towards melanoma. Patients with oculodermal melanocytosis merit regular long-term surveillance for early detection of melanoma, not only in the uvea, but also in the orbit and potentially the ocular surface.

2 March 2021 in Clinical and Experimental Optometry
Verified
Journal Article
Closed access
OSOmar Salehi
Omar Salehi
PWPeter van Wijngaarden
Peter van Wijngaarden
SKStuart Keel
Stuart Keel
JFJoshua Foreman
Joshua Foreman
MDMohamed Dirani
Mohamed Dirani
RORoderick O'Day
Roderick O'Day
Clinical relevance: The malignant potential of choroidal melanocytic tumours detected incidentally in the community is thought to be low, but this has not been assessed using a validated screening tool. An accurate characterisation of the malignant potential of these lesions has implications for resource allocation, service provision, education, and training. Background: MOLES (Mushroom shape, Orange Pigment, Large size, Enlargement, and Subretinal fluid) categorises tumours as ‘common naevus’, ‘low-risk naevus’, ‘high-risk naevus’, and ‘probable melanoma’. The MOLES system recommends that patients with common naevi (score = 0) undergo review by a community optometrist every two years, ideally with sequential colour photography. For the remaining patients (score ≥ 1), specialist imaging and assessment are recommended, with referral triaged as non-urgent for patients with low-risk (score = 1) or high-risk naevi (score = 2) and urgent for patients with probable melanoma (score > 2). Methods: Lesions flagged as choroidal melanocytic tumours on retinal photographs taken during the Australian National Eye Health Survey were retrospectively analysed by an ocular oncologist. Each lesion was assigned a MOLES score and categorised as common, low-risk, high-risk or probable melanoma. Results: Seventy-seven choroidal naevi were identified. Seventy-five (97%) of the choroidal naevi were categorised as common naevi, with a MOLES score of 0. Two (3%) choroidal naevi had a score of 1 and diagnosed as low-risk naevi due to their size. No naevi had a score of 2 or more. Conclusion: All choroidal naevi detected in this nationally representative population survey were innocuous. This suggests that the vast majority of choroidal melanocytic tumours that are incidentally detected in Australia can be managed in primary eye care settings without the need for specialist referral. MOLES provides a simple evidence-based method for choroidal naevi assessment in primary care.